Francisco de Vitoria University
Madrid, 28223, Spain
NCT Number: NCT06008886
This study aimed to evaluate the effect of a vegan diet (supplemented with vitamin B12) and an mediterranean diet on performance, cardiorespiratory fitness, metabolic health, immune status, and environmental impact in healthy adults.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
Madrid, 28223, Spain
OMNIVEG is a controlled crossover trial. Initially, registered dietitians conducted an assessment of participants' lifestyles in a preliminary session. Qualified nutritionists then developed personalized diets for each participant in accordance with the recommendations of the International Society of Sports Nutrition (ISSN). These diets followed specific guidelines, including a daily intake of 3-5 g of carbohydrates per kilogram of body weight, 1.4-2.0 g of protein per kilogram of body weight, and 0.5-1.5 g of fat per kilogram of body weight.
Both the mediterranean diet and vegan diets prescribed to the participants were isocaloric, with similar distributions of macronutrients. The primary difference between the two interventions was the source of food: the vegan diet exclusively comprised plant-based foods, while the omnivorous diet included foods of both animal and plant sources. In the case of the omnivorous diet, 60% of the total protein intake was derived from animal sources (mainly from fish, white meat, low-fat dairy and eggs).
As part of the vegan diet, participants were instructed to take 1000 µg of cyanocobalamin (a form of vitamin B12) twice a week from Harrison Sport Nutrition, Granada, Spain. This supplementation aimed to ensure adequate vitamin B12 intake, which is essential for individuals following a vegan diet.
Throughout the study period, participants were advised to maintain their initial physical exercise frequency and volume to maintain consistency and avoid confounding variables. To ensure standardized measurements, all tests were conducted in the same laboratory, employing identical testing devices, and supervised by the same group of researchers. This approach aimed to minimize experimental variability and improve the reliability of the study's results.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Normocaloric diet based solely on foods of plant sources.
Diet with a predominance of plant foods fruits, vegetables, whole grains, nuts and legumes); moderate to low consumption of fish, white meat, low-fat dairy and eggs; and very low consumption of red and processed meats, butter, full-fat dairy and sweets.
Time frame: 4 weeks
Cardiorespiratory fitness was measured using Maximal oxygen uptake (VO2max).
Time frame: 4 weeks
Metabolic health was measured using serum total cholesterol (TC), cholesterol-LDL (LDL-c) and colesterol-HDL (HDL-c)
Time frame: 4 weeks
Performance was measured using FATmax (g/min).
Time frame: 4 weeks
Performance was measured using countermovement (CMJ) (W) and squat jump (SJ).
Time frame: 4 weeks
Performance was measured using squat jump (SJ) (W)
Time frame: 4 weeks
Environmental impact was measured using Global-warming potential-100
Time frame: 4 weeks
Inmune status was measured using lymphocyte levels (109/L )
Time frame: 4 weeks
Performance was measured using handgrip
Time frame: 4 weeks
Metabolic health was measured using systolic blood pressure (SBP) and diastolic blood pressure (DBP).
Time frame: 4 weeks
Inmune status was measured using monocyte, eosinophils and neutrophils levels (10^9/L)
Time frame: 4 weeks
Environmental impact was measured using blue water footprint and land use.
Universidad Francisco de Vitoria
Other
Effect of a Vegan Diet Versus a Mediterrean Diet on Performance, Cardiorespiratory Fitness, Metabolic Health, Immune Status, and Environmental Impact in Healthy Adults
Acronym: OMNIVEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04776629
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT06501001
Behavior, Body Weight
Toledo, Spain
View Trial DetailsNCT05192590
Cardiometabolic Syndrome, Glucose Metabolism Disorders
San Francisco, California, United States
View Trial DetailsNCT05622006
Behavior, Cardiometabolic Syndrome
Oslo, Norway
View Trial Details